1α, 25-dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor

International Journal of Obesity

Volumn 32, Issue 8, 2008, Pages 1305-1311

  Sun, X ^a   Zemel, M B ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

1 , 25 dihydroxyvitamin D; Adipocyte; Corticosteroid; nVDR

Indexed keywords

11BETA DEHYDROCORTICOSTERONE; 11BETA HYDROXYSTEROID DEHYDROGENASE; CALCITRIOL; CALCITRIOL RECEPTOR; CORTICOSTEROID; CORTICOSTERONE DERIVATIVE; DEXAMETHASONE; ISOBUTYLMETHYLXANTHINE; LUMISTEROL; 1,25 DIHYDROXYVITAMIN D4; 1,25-DIHYDROXYVITAMIN D4; DRUG DERIVATIVE; GLUCOCORTICOID; UNCLASSIFIED DRUG; VITAMIN D;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; HORMONE RELEASE; HORMONE SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADIPOGENESIS; ANIMAL; CELL CULTURE; CELL NUCLEUS; DRUG EFFECT; METABOLISM; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

1-METHYL-3-ISOBUTYLXANTHINE; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; DEXAMETHASONE; GLUCOCORTICOIDS; MICE; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VITAMIN D;

EID: 49449116730     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2008.59     Document Type: Article

References (33)

1. Zemel MB. Calcium and dairy modulation of obesity risk. Obes Res 2005; 13: 192-193.
2. Zemel MB. Dairy Foods, calcium and weight management. In: D Bagchi, H Preuss (eds). Obesity Epidemiology, Pathophysiology and Prevention. CRC Press: Boca Raton, 2007, pp 477-493.
3. Shi H, Dirienzo D, Zemel MB. Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J 2001; 15: 291-293.
4. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB. 1 alpha, 25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J 2001; 15: 2751-2753.
5. Xue B, Greenberg AG, Kraemer FB, Zemel MB. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J 2001; 15: 2527-2529.
6. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB. 1alpha, 25-dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes. FASEB J 2002; 16: 1808-1810.
7. Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, Hollenberg AN. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 2006; 281: 11205-11213.
8. Morris KL, Zemel MB. 1,25-dihydroxyvitamin D3 modulation of adipocyte glucocorticoid function. Obes Res 2005; 13: 670-677.
9. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J 2000; 14: 1132-1138.
10. Xiaoyu Z, Payal B, Melissa O, Zanello LP. 1alpha,25(OH)2-vitamin D3 membrane-initiated calcium signaling modulates exocytosis and cell survival. J Steroid Biochem Mol Biol 2007; 103: 457-461.
11. Picotto G. Rapid effects of calciotropic hormones on female rat enterocytes: combined actions of 1,25(OH)2-vitamin D3, PTH and 17beta-estradiol on intracellular Ca2+ regulation. Horm Metab Res 2001; 33: 733-738.
12. Capiati DA, Vazquez G, Tellez Inon MT, Boland RL. Role of protein kinase C in 1,25(OH)(2)-vitamin D(3) modulation of intracellular calcium during development of skeletal muscle cells in culture. J Cell Biochem 2000; 77: 200-212.
13. Koster HP, Hartog A, Van Os CH, Bindels RJ. Calbindin-D28K facilitates cytosolic calcium diffusion without interfering with calcium signaling. Cell Calcium 1995; 18: 187-196.
14. Gascon-Barre M, Haddad P, Provencher SJ, Bilodeau S, Pecker F, Lotersztajn S et al. Chronic hypocalcemia of vitamin D deficiency leads to lower intracellular calcium concentrations in rat hepatocytes. J Clin Invest 1994; 93: 2159-2167.
15. Zemel MB, Miller SL. Dietary calcium and dairy modulation of adiposity and obesity risk. Nutr Rev 2004; 62: 125-131.
16. Xue B, Moustaid-Moussa N, Wilkison WO, Zemel MB. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism. FASEB J 1998; 12: 1391-1396.
17. Zemel MB. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem 1998; 188: 129-136.
18. Petrov V, Lijnen P. Modification of intracellular calcium and plasma renin by dietary calcium in men. Am J Hypertens 1999; 12: 1217-1224.
19. Rao RM, Yan Y, Wu Y. Dietary calcium reduces blood pressure, parathyroid hormone, and platelet cytosolic calcium responses in spontaneously hypertensive rats. Am J Hypertens 1994; 7: 1052-1057.
20. Rohe B, Safford SE, Nemere I, Farach-Carson MC. Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS)-binding protein in rat IEC-6 cells. Steroids 2005; 70: 458-463.
21. Ye WZ, Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol 2001; 145: 181-186.
22. Barger-Lux MJ, Heaney RP, Hayes HF, DeLuca HF, Johnson ML, Gong G. Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density. Calcif Tissue Int 1995; 57: 161-162.
23. Andersen T, McNair P, Hyldstrup L, Fogh AN, Nielsen TT, Astrup A et al. Secondary hyperparathyroidism of morbid obesity regresses during weight reduction. Metabolism 1988; 37: 425-428.
24. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370-373.
25. Sun X, Zemel MB. Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice. J Nutr 2004; 134: 3054-3060.
26. Rayalam S, Della-Fera MA, Ambati S, Boyan B, Baile CA. Enhanced effects of guggulsterone plus 1,25(OH)2D3 on 3T3-L1 adipocytes. Biochem Biophys Res Commun 2007; 364: 450-456.
27. Vu D, Ong JM, Clemens TL, Kern PA. 1,25-Dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation. Endocrinology 1996; 137: 1540-1544.
28. Jamieson PM, Chapman KE, Edwards CR, Seckl JR. 11β-hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: Effect of physiochemical and hormonal manipulations. Endocrinology 1995; 136: 4754-4761.
29. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166-2170.
30. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003; 112: 83-90.
31. Sutton AL, MacDonald PN. Vitamin D: more than a 'bone-a-fide' hormone. Mol Endocrinol 2003; 17: 777-791.
32. Whitfield GK, Jurutka PW, Haussler CA, Haussler MR. Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function. J Cell Biochem 1999; 75 (Suppl 32): 110-122.
33. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD et al. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 2000; 14: 27-39.